[Neuroendocrine expression markers in triple-negative, luminal-A, luminal-B and HER2neu breast cancer].
Yesica Guadalupe Barboza-GarcíaLázaro Ariel Ramírez-BalderramaMario Murguia-PerezMartha Alicia Hernández-GonzalezIsette Yunue Landeros-NavarroPublished in: Revista medica del Instituto Mexicano del Seguro Social (2024)
The NE differentiation prevalence was 26.3% in primary invasive breast cancers, with luminal-A molecular type predominance.
Keyphrases